EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Electromedical Technologies, Inc

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024

$0.00+0.00 (+9900.00%)

Close on Oct 19, 2026

Market cap: $68.10K
P/E (TTM): –
Dividend yield: –

Electromedical Technologies, Inc income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	1.35	1.15	0.91	0.74	0.83
Cost of Revenue	0.30	0.26	0.20	0.19	0.24
Gross Profit	1.05	0.89	0.71	0.54	0.59
Research & Development	0.23	0.09	0.22	0.03	0.08
Selling, General & Admin	3.11	2.49	4.51	3.71	2.26
Advertising Expenses	–	–	–	0	0
Operating Income	-2.06	-1.60	-3.80	-3.17	-1.67
Interest Expense	0.89	0.79	3.31	0.77	0.05
Other Non-Operating Income	-0.58	-1.86	-4.68	-0.71	-0.08
Asset Impairment Charges	0	0	0	0	0
Gain (Loss) on Sale of Assets	1.19	–	–	–	–
Net Income incl. Noncontrolling Interests	-2.64	-3.47	-8.48	-3.87	–
Net Income	-2.64	-3.47	-8.48	-3.87	-1.74
Net Income to Common	-2.64	-3.58	-12	-4.38	–
EPS (Basic)(per share)	0.00	-0.03	-0.24	-0.20	-0.10
EPS (Diluted)(per share)	0.00	-0.03	-0.24	-0.20	-0.10
Shares Outstanding (Basic, Weighted)(shares)	377	134	51	22	17
Shares Outstanding (Diluted, Weighted)(shares)	377	134	51	22	17
EBITDA	-2.06	-1.58	-3.78	-3.14	-1.64

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2024

Profitability, TTM

Gross margin: 75.1%
Operating margin: -109.6%
Net margin: -182.0%
Return on equity, FY2023: 103.7%

Financial strength

Current ratio: 0.07
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.8%

Valuation

P/E ratio: –
Price to sales: 0.07
Price to book: –
Dividend yield: –